Chemours Co. — Q1 2024 Form 10-Q
Reporting period: Three months ended March 31, 2024; comparisons are with Q1 2023 unless otherwise noted. Chemours is a global performance-chemicals producer operating through Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. Financial amounts are in millions of dollars unless indicated.
Financial performance
| Metric | Q1 2024 | Q1 2023 |
|---|---|---|
| Net sales | $1,350 | $1,536 |
| Gross profit | $286 | $368 |
| Income before taxes | $67 | $173 |
| Net income | $52 | $145 |
| Diluted EPS | $0.34 | $0.96 |
| Operating cash flow | $(290) | $(124) |
| Capital expenditures | $102 | $91 |
- Sales fell 12%: price declined 5%, volume 6%, and portfolio effects 1%; currency was flat in the consolidated sales bridge. Cost of goods sold decreased 9%, but gross profit declined and gross margin was approximately 21.2%, versus 24.0%.
- Segment Adjusted EBITDA was $253, down from $349. Titanium Technologies was $70 (unchanged; 12% margin versus 11%); Thermal & Specialized Solutions was $151 (down from $185; 34% margin versus 38%); Advanced Performance Materials was $30 (down from $84; 10% margin versus 22%).
- Interest expense, net rose to $63 from $42, primarily reflecting higher variable rates and debt issued in August 2023. SG&A increased to $142 from $124, partly due to the Audit Committee review and transformation-plan costs.
- Cash used in operations increased to $290, driven chiefly by working-capital outflows and lower earnings. Investing cash use was $101; financing cash use was $54, including $37 of dividends. The quarterly dividend was $0.25 per share.
- At March 31, cash and cash equivalents were $746, restricted cash was $607, and current assets and current liabilities were $3,597 and $2,231, respectively. Restricted cash is principally tied to the public-water-system settlement and is not equivalent to unrestricted operating cash.
- Debt principal was $4,051, including $3,891 of senior debt; long-term debt, net, was $3,968. No revolver borrowings were outstanding. Revolver availability was $853 after letters of credit, and the company reported covenant compliance.
Material changes and operating context
- Advanced Performance Materials sales fell 23%, mainly on an 18% volume decline from weaker demand in economically sensitive and non-strategic markets and the tail effect of a prior maintenance outage. The outage was resolved; inventory was rebuilt in Q1.
- Thermal & Specialized Solutions sales declined 8% on lower automotive OEM and foam/propellant volumes and weaker legacy refrigerant pricing. Titanium Technologies sales fell 7%, primarily due to lower prices; transformation-plan savings helped keep segment Adjusted EBITDA flat.
- Management attributed Q1 working-capital pressure partly to prior-year-end actions. The Audit Committee found former senior executives sought to defer up to approximately $100 of vendor payments and accelerate up to approximately $260 of receivables into Q4 2023, in part to meet communicated free-cash-flow targets and incentive metrics. Similar, smaller timing actions occurred in Q4 2022. The reversal adversely affected Q1 cash flows.
- The filing revised prior-period supplier-financing presentation: certain obligations were reclassified from accounts payable to debt, and related cash flows from operating to financing. Management said the errors were immaterial to previously issued statements; Q1 2023 operating cash flow remained $(124) after revision.
Outlook, risks, contingencies, and unusual items
- No specific full-year earnings or sales guidance is provided in the supplied filing text. Management expects liquidity sources to fund planned operations and obligations through at least the end of May 2025, and expects unrestricted cash to decline by approximately $475 in the first half of 2024, with most of the decline occurring in Q1.
- The company reported $784 of accrued litigation, including $710 for PFAS matters. The $592 Chemours share of the U.S. public water-system settlement was funded into a qualified settlement fund; following final judgment in April 2024, Chemours expects to derecognize the related restricted cash and accrued liability in Q2. The settlement does not resolve all opt-outs or other PFAS claims.
- Environmental remediation liabilities were $581, including $378 for Fayetteville. Management estimates potential environmental liabilities could be up to approximately $730 above recorded accruals under adverse changes; this is not an estimate of maximum exposure. Many PFAS-related potential losses remain unestimable. The filing also describes new U.S. EPA PFAS drinking-water limits and CERCLA designations issued in April 2024, which may create additional costs.
- Material weaknesses in internal control over financial reporting continued at March 31, and disclosure controls and procedures were deemed ineffective. The company cited weaknesses involving tone at the top, information sharing, ethics-hotline escalation, and vendor-master-file changes. Management stated the interim financial statements were fairly stated in all material respects and described remediation actions underway.
- The Audit Committee review led to former CEO, CFO, and Controller being placed on administrative leave; the company appointed a new CEO and interim CFO. The company is cooperating with SEC and U.S. Attorney requests for information and faces securities class actions and a stockholder books-and-records demand; outcomes and potential losses are not estimable.
- Credit-rating actions are a concern: Moody’s placed ratings under review for downgrade, while S&P affirmed BB- with a negative outlook. Variable-rate debt, refinancing needs, PFAS litigation, environmental obligations, and evolving U.S. and EU regulation are material risks.
- The company expects to pay $55 for the Ohio settlement and approximately $13 for a supplemental Delaware payment in 2024. It also expects up to $10 of additional charges for Kuan Yin site decommissioning, dismantling, and removal activities.
Important facts for investors to verify
- Progress and independent validation of control remediation, and any further findings from regulators or the Audit Committee review.
- Underlying operating cash generation after the working-capital timing reversals, and the availability and terms of liquidity facilities.
- Segment demand, pricing, margins, and recovery in Advanced Performance Materials and Thermal & Specialized Solutions.
- Q2 accounting and cash effects from the public-water settlement fund, plus developments in opt-out, PFAS, Fayetteville, and other environmental claims.
- Actual environmental spending and whether EPA rules, remediation plans, or regulatory outcomes require accruals beyond the $581 recorded liability.
- Debt refinancing and rating developments, particularly the 2026 note maturity and the credit agreement’s springing-maturity provision.